SV2A and Alzheimer disease: In this study, SV2A levels were found to be significantly decreased in postmortem hippocampal and cortex of donors with AD, as well as in CSF and serum of aMCI and AD patients, and their levels were significantly correlated with cognitive scores (Figure S2).